Epileptic seizure during aspirin and caffeine withdrawal in a drug induced headache

Functional Neurology

Volumn 11, Issue 6, 1996, Pages 333-337

  Antonaci, Fabio ^a,c   Sances, Grazia ^a   Manni, Raffaele ^b   Buzzi, Maria Gabriella ^a  

^a IRCCS NEUROMED   (Italy)

^b C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

Author keywords

aspirin; caffeine; headache; seizures; withdrawal

Indexed keywords

ACETYLSALICYLIC ACID; CAFFEINE; CAFIASPIRINA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; DRUG ABUSE; DRUG WITHDRAWAL; FEMALE; HEADACHE; HUMAN; SEIZURE; WITHDRAWAL SYNDROME;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; DRUG COMBINATIONS; EPILEPSY, TONIC-CLONIC; FEMALE; HEADACHE; HUMANS; MIDDLE AGED; MIGRAINE DISORDERS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0030424711     PISSN: 03935264     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Diener HC. Klinik des Analgetikakopkschmerzes. Dtsch Med Wochenschr 1988; 113: 472-474
2. Granella F, Farina S, Malferrari G, Manzoni GC. Drug abuse in chronic headache: a clinico-epidemiologic study. Cephalalgia 1987;7:15-19
3. Saper JR. Drug overuse among patients with headache. In: Packard RC ed Neurologic clinics. Vol 1. N. 2 Philadelphia; Saunders 1983:465-477
4. Micieli G, Manzoni GC, Granella F, Martignoni E, Malferrari G, Nappi G. Clinical and epidemiological observations on drug abuse in headache patients. In: Diener HC, Wilkinson M eds Drug-induced headache. Berlin, Heidelberg; Springer Verlag 1988:20-28
5. Baumgartner C, Wessely P, Bingol C, Maly J, Holzner F. Long-term prognosis of analgesic withdrawal in patients with drug-induced headaches. Cephalalgia 1989;29: 510-519
6. Nehlig A, Daval JL, Debry G. Caffeine and central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Res Brain Res Rev 1992;17:139-170
7. Griffiths RR, Woodson PP. Caffeine physical dependence: a review of human and laboratory animal studies. Psychopharmacology (Berl) 1988;94:437-451
8. Silverman K, Evans SM, Strain EC, Griffiths RR. Withdrawal syndrome after the double blind cessation of caffeine consumption. New Engl J Med 1992;327:1109-1114
9. Evans SM, Griffiths RR. Low-dose caffeine physical dependence in normal subjects: dose related effects. In: Harris L ed Problems of drug dependence 1990. Proceeding of the 52nd Annual Scientific Meeting, the Committee on Problems on Drug Dependence, INC NIDA Research Monograph 105. Washington DC; Government Printing Office 1991:446-447
10. Griffiths RR, Evans SM, Heishman SJ et al. Low-dose caffeine physical dependence in humans. J Pharmacol Exp Ther 1990; 255:1123-1132
11. Greden JF, Victor BS, Fontaine P, Lubetsky M. Caffeine-withdrawal headache: a clinical profile. Psychosomatics 1980;21:411-413
12. Akita I, Suwaki H, Ikeda H. Clouding of consciousness on the withdrawal of caffeine and sodium benzoate. Arukoru Kenkiuto Yakubutsu Ison 1988;23:12-17
13. Zanferrari C, Bizzi P, Sasso E, Granella F, Manzoni GC. Sindrome da astinenza da barbiturici dopo brusca interruzione dell'uso quotidiano di Optalidon in tre casi di cefalea. Confinia Cephalalgica 1992;1: 49-53
14. Smith CM, Reynard AM, Textbook of Pharmacology. WB Saunders; London 1993
15. Paul S, Kurunwune B, Biaggioni I. Caffeine withdrawal: apparent heterologous sensitization to adenosine and prostacyclin actions in human platelets. J Pharmacol Exp Ther 1993;267:838-843